Tag: China

Broad Success for Chinese Pilot Project to Negotiate National Formulary Approval for Innovative Medicines

Lawrenceville, NJ, USA—August 22, 2018—Value in Health Regional Issues, a MEDLINE®-indexed journal of ISPOR (the professional society for health economics and outcomes research), announced today the publication of an article highlighting the positive results of a pilot project launched by

Posted in Announcements, ISPOR News & Press, Value in Health Regional Issues Tagged with: , ,

ENSURING THE FUTURE FOR CHINA’S ESSENTIAL DRUG POLICY

New Orleans, LA, USA & Shandong, China – China is one of the few middle-income countries with higher pharmaceutical cost out of total health care spending. The primary purpose of China’s National Essential Drug Policy (NEDP) in year 2009 was

Posted in Health Policy Analyses, Value in Health Regional Issues Tagged with: , , ,

ASSURE SAFETY IN INTRAVENOUS MEDICATION USE IN CHINA

Beijing, China – Chinese inpatients have experienced overuse of intravenous medications, with a total of 10.4 billion infusion bottles for 1.3 billion Chinese people annually, approximately 8 infusion bottles per capita in 2009. However, few studies have yet been published

Posted in Comparative Effectiveness Research / Health Technology Assessment, ISPOR News & Press, Value in Health Regional Issues Tagged with: , , ,

What Does the Future of Health Technology Assessment Hold for Mainland China, Japan, South Korea, and Taiwan?

Indianapolis, IN, USA – Diabetes mellitus (DM) is associated with significant economic and humanistic burden. The condition presents a real challenge in Asia, which accounts for more than 60% of individuals with DM, globally.

Posted in Value in Health Regional Issues Tagged with: , , , , ,

A Cost-Effective Antibiotic For Hospital Acquired Pneumonia

Beijing, China – Linezolid is a relatively new approved antibiotic in China for the treatment of hospital-acquired pneumonia.  As linezolid has been shown to be a cost-effective alternative in comparison to vancomycin in many countries such as the USA, Germany and

Posted in Value in Health Regional Issues Tagged with: , ,

Why Does Anti-Infective Drug Expenditure Increase In China?

Tianjin, China – There has been a growing concern regarding high pharmaceutical expenditure around the world, which is an extreme focus in China as it accounts for more than a half of the total health expenditure. Over the past decade, although

Posted in Value in Health Regional Issues Tagged with: ,

What Are The Important Factors In Selecting TCM?

Shenyang, China & Newcastle, Australia – The use of traditional Chinese medicine (TCM) has been gaining momentum in the past decades internationally. Even with quite a sizeable consumption and expenditure, there are still many barriers that prevent TCM to be reimbursed

Posted in Value in Health Regional Issues Tagged with: , , ,